Molecular Minute Podcasts

September 2021

Episode 24 – Interview with Dr. Igor Astsaturov: Molecular Tumor Boards

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Igor Astsaturov, Co-director of the Pancreatic Institute at Fox Chase Cancer Center and Chairman of the Caris Molecular Tumor Board . Together they discuss molecular tumor boards and how they are utilized at Caris and other academic sites.

Episode 23 – Interview with Dr. Charu Aggarwal: Top thoracic data and abstracts from ASCO 2021

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Elisabeth Heath, Associate Center Director of Translational Sciences at Karmanos Cancer Institute. Together they discuss the latest findings and top abstracts in GU oncology that were presented at this year’s ASCO meeting.

Episode 22 – Interview with Dr. Charu Aggarwal: Top thoracic data and abstracts from ASCO 2021

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Charu Aggarwal, the Leslye Heisler Assistant Professor of Medicine in the Hematology-Oncology Division at the University of Pennsylvania’s Perelman School of Medicine. Together they discuss the latest findings and top abstracts in thoracic oncology that were presented at this year’s ASCO meeting.

Episode 21 – Interview with Dr. Shaalan Beg: Top GI data and abstracts from ASCO 2021

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Shaalan Beg, Director for Gastrointestinal (GI) Medical Oncology at UT Southwestern to discuss the latest findings and top abstracts in GI that were presented at this year’s ASCO meeting.

Episode 20 – Interview with Dr. Trisha Wise-Draper: Advances in head and neck cancers.

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Trisha Wise-Draper, Assistant Professor of Medicine in the Division of Oncology at the University of Cincinnati. Together they discuss the latest advances in head and neck cancers as well as findings from this year’s ASCO meeting.

Episode 19 – Interview with Dr. Neeraj Agarwal: Genomic profiling and sequencing in GU malignancies.

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Neeraj Agarwal, Director of the Genitourinary Oncology Program at the Huntsman Cancer Institute. Together they discuss genomic profiling and sequencing in GU malignancies.

Episode 18 – Interview with Dr. Sonikpreet Aulakh: The impact of precision oncology on brain tumors.

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Sonikpreet Aulakh, Assistant Professor of Medicine in translational neuro-oncology from West Virginia University to discuss the impact of precision oncology on the treatment of brain tumors.

Episode 17 – Interview with Dr. Heloisa Soares: Neuroendocrine tumors (NETs).

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Heloisa Soares, a medical oncologist at the Huntsman Cancer Institute (HCI) at the University of Utah. Together they discuss the latest treatments in neuroendocrine tumors (NETs) and the elements that allow us to understand the prognosis on both molecular and histopathology levels.

Episode 16 – Interview with Dr. Olga Weinberg: Pediatric cancers and pediatric oncology.

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Olga Weinberg who is a hematopathologist and Director of Fellowship Education at UT Southwestern Medical Center. Together they discuss pediatric oncology and the applicability of NGS to these types of cancers.

Episode 15 – Interview with Dr. Don Dizon: The impact of genomic profiling and sequencing in GYN malignancies.

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Don Dizon, Director of Women’s Cancers at Brown University’s Lifespan Cancer Institute. Together they discuss precision oncology and the impact of genomic profiling and sequencing in the management of women with various gynecological malignancies.

Episode 14 – Interview with Dr. Paolo Ascierto: Advances in immunotherapy and melanoma.

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Paolo Ascierto, Director of the Unit of Melanoma and the Oncological Immunotherapy and Innovative Therapies Director at the National Tumor Institute “Fondazione G. Pascale”, in Naples, Italy. As the founder of both the Melanoma Bridge Meeting and the Immunotherapy Bridge Meeting, Dr. Ascierto shares outcomes from both meetings as well as insights into the latest treatments in both disease states.

Episode 13 – Interview with Dr. Rana McKay: Top abstracts from ASCO GU 2021.

Dr. Rana McKay, Associate Professor of Medicine from the University of California San Diego Health, joins Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, to discuss the top abstracts to come out of this year’s ASCO GU virtual meeting in the areas of prostate, bladder and kidney.

Episode 12 – Interview with Dr. Matt Oberley: Genomic profiling in Cancers of Unknown Primary (CUP).

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Matt Oberley, Executive Medical Director at Caris Life Sciences, to discuss how genomic profiling and genomic studies might help clinicians to determine the origin of tumors in Cancer of Unknown Primary (CUP).


Episode 11 – Interview with Dr. Emil Lou: Advances in GI oncology.

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Emil Lou, Associate Professor of Medicine in the Division of Hematology, Oncology and Transplantation at the University of Minnesota, to discuss the recent advances and future of GI oncology.

Episode 10 – Interview with Dr. John Marshall / Dr. Tony Shields: MI FOLFOXai™

In this interview Dr. Marshall and Dr. Shields discuss the findings of their paper and how we can better predict which metastatic colorectal cancer patients will benefit from first-line FOLFOX+BV followed by FOLFIRI+BV or vice versa.

Episode 9 – Interview with Dr. Marcus Neubauer: Precision oncology in community settings.

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Marcus Neubauer, Chief Medical Officer of the US Oncology Network, to discuss the challenges and opportunities of precision oncology in the community setting and how it is evolving.

Episode 8 – Interview with Dr. Tian Zhang: Advances in prostate cancer.

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Tian Zhang, Assistant Professor of Medicine at Duke University, to discuss the recent advances in prostate cancer and abstracts that were presented at this year’s virtual ASCO meeting.

Episode 7 – Interview with Dr. Virginia Kaklamani: Breast cancer and patient care.

Caris Precision Oncology Alliance™ Chairman, Chadi Nabhan, sits down with Dr. Virginia Kaklamani from the University of Texas Health San Antonio, to discuss changes in the approach to both metastatic breast cancer and early stage breast cancer, and how these changes are impacting patient care.

Episode 6 – Interview with Laura Holmes Haddad: Patient advocate and breast cancer survivor.

Caris Precision Oncology Alliance™ Chairman, Chadi Nabhan, sits down with patient advocate Laura Holmes Haddad to discuss her personal journey with breast cancer and precision oncology.

Episode 5 – Interview with Dr. Geoff Gibney: Evolving strategies in treating melanoma.

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, discusses evolving strategies in treating melanoma in the era of precision oncology with Dr. Geoff Gibney from Georgetown University.

Episode 4 – Interview with Dr. Michael Korn: FOLFOXai™ predictor

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Michael Korn, Chief Medical Officer at Caris Life Sciences to discuss the MI FOLFOXai™ predictor of response to FOLFOX chemotherapy in metastatic colorectal cancer.

Episode 3 – Intreview with Dr. Tian Zhang: Urothelial updates from ASCO 2020.

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Tian Zhang from Duke University to discuss the recent advances and data in urothelial cancer presented at this years virtual ASCO meeting.

Episode 2 – Interview with Dr. Stephen Liu: Lung cancer updates from ASCO 2020.

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Stephen Liu from MedStar Georgetown University Hospital to discuss the latest lung cancer updates to come from this year’s ASCO meeting.

Episode 1 – Interview with Dr. David Spetzler: Precision Medicine

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. David Spetzler, President and Chief Scientific Officer at Caris Life Sciences, to discuss precision medicine.

Share to: